Skip to main content

Search datasets

#1 Federal
Losartan and diabetic nephropathy: commentaries on the RENAAL study
- Organization: U.S. Department of Health & Human Services
- Dataset Last Updated: September 06, 2025
The RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan) study is a multinational, double-blind, randomized, placebo controlled trial which was recently published....
- HTML
Search relevance: 1.00 | Views last month: 4 | Catalog Last Checked: July 31, 2026 at 08:59 PM
#2 Federal
Apolipoprotein E gene polymorphism is not a strong risk factor for diabetic nephropathy and retinopathy in Type I diabetes: case-control study
- Organization: U.S. Department of Health & Human Services
- Dataset Last Updated: September 06, 2025
Background The gene encoding apolipoprotein E (APOE) has been proposed as a candidate gene for vascular complications in Type I diabetes. This study aimed to investigate the influence of...
- HTML
Search relevance: 1.00 | Views last month: 3 | Catalog Last Checked: July 31, 2026 at 09:11 PM

Filter selections are applied on each click

Looking for U.S. government information and services?

Visit USA.gov